Darren Feldman, MD
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Darren Feldman, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:39 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05239533 · Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney CancerMemorial Sloan Kettering Cancer Center · active not recruiting · Clear Cell Renal Cell Carcinoma, Kidney Cancer, Advanced Renal Cell Carcinoma · principal investigator
- Ph2NCT03635892 · A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell CarcinomaMemorial Sloan Kettering Cancer Center · active not recruiting · Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma · principal investigator
- Ph3NCT02375204 · Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell TumorsAlliance for Clinical Trials in Oncology · active not recruiting · Germ Cell Tumor, Teratoma, Choriocarcinoma · study chair
- N/ANCT02099734 · Germ Cell Tumor and Testicular Tumor DNA RegistryMemorial Sloan Kettering Cancer Center · recruiting · Germ Cell Tumor, Testicular Tumor · principal investigator
- Ph2NCT01873326 · Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell TumorsMemorial Sloan Kettering Cancer Center · active not recruiting · Germ Cell Tumors · principal investigator
- N/ANCT01582204 · Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell CarcinomaMemorial Sloan Kettering Cancer Center · active not recruiting · Renal Cancer · principal investigator
- N/ANCT01453660 · Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor ControlsMemorial Sloan Kettering Cancer Center · active not recruiting · Germ Cell Cancer · principal investigator
- Ph2NCT01399918 · Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)Memorial Sloan Kettering Cancer Center · completed · Renal Cell Carcinoma · principal investigator
- Ph2NCT00470366 · Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell TumorsMemorial Sloan Kettering Cancer Center · completed · Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor, Ovarian Cancer · principal investigator
- Ph1/Ph2NCT00423852 · Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to CisplatinMemorial Sloan Kettering Cancer Center · completed · Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor, Ovarian Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Alliance for Clinical Trials in Oncology Member Site CoreU10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026Named on NCT02375204
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.